Pharming Group
Tracked across 2 events · 12 articles · First seen Apr 07, 2026 · Last active Aug 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Pharming Group will participate in investor conferences to present its business and engage with investors, potentially increasing its visibility and investor interest.
Apr 07, 2026 · 6 articles
Regulatory
Levi & Korsinsky, a securities litigation firm, has commenced an investigation into Pharming Group N.V. (NASDAQ: PHAR) concerning potential violations of federal securities laws. The investigation follows a 22% drop in Pharming's stock on July…
Impact: Pharming Group is the subject of the investigation and experienced a 22% stock drop after reporting weak Q2 results and cutting guidance. The company faces potential securities litigation and reputational damage, with its legacy product RUCONEST under competitive pressure.
Jul 31, 2026 · 6 articles
85
Pharming Group reported Q2 revenuePharming Group Securities...
80
Pharming Group saw stock dropPharming Group Securities...
80
Levi & Korsinsky commenced investigation Pharming GroupPharming Group Securities...
ERGEN INTELLIGENCE
Track Pharming Group live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard